Bio-Techne
TECH
#1539
Rank
HK$86.65 B
Marketcap
HK$545.37
Share price
1.97%
Change (1 day)
10.06%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$4.64 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are HK$4.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30HK$5.26 B13.1%
2022-06-30HK$4.65 B-13.24%
2021-06-30HK$5.37 B7.19%
2020-06-30HK$5.00 B-10.8%
2019-06-30HK$5.61 B39.19%
2018-06-30HK$4.03 B-15.04%
2017-06-30HK$4.74 B144.57%
2016-06-30HK$1.94 B15.76%
2015-06-30HK$1.67 B221.96%
2014-06-30HK$0.52 B65.64%
2013-06-30HK$0.31 B-9.65%
2012-06-30HK$0.34 B41.83%
2011-06-30HK$0.24 B85.17%
2010-06-30HK$0.13 B10.21%
2009-06-30HK$0.12 B-23.76%
2008-06-30HK$0.15 B17.42%
2007-06-30HK$0.13 B-42.61%
2006-06-30HK$0.23 B10.01%
2005-06-30HK$0.21 B-2.64%
2004-06-30HK$0.21 B5.16%
2003-06-30HK$0.20 B-16%
2002-06-30HK$0.24 B-16.21%
2001-06-30HK$0.29 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$398.97 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.24 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$231.24 B 4,873.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$228.11 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$16.96 B 264.83%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$837.37 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.23 B-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA